Showing results (21-30 of 106) with videos related to
Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|January 1, 1986
Comparison of the pharmacokinetics and protein binding of the anticancer drug, amsacrine and a new analogue, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino)phenyl-amino] -4-acridinecarboxamide in rabbitsJ W Paxton, J L JurlinaPharmacology|January 1, 1985
Elimination kinetics of amsacrine in the rabbit: evidence of nonlinearityJ W Paxton, J L JurlinaJournal of Pharmacological Methods|August 1, 1983
Propranolol binding in serum: comparison of methods and investigation of effects of drug concentration, pH, and temperatureJ W Paxton, R L CalderJournal of Chromatography|September 9, 1983
High-performance liquid-chromatographic method for the determination of 4'-(9-acridinylamino)methanesulfon-m-anisidide in plasmaJ L Jurlina, J W PaxtonClinical Pharmacology and Therapeutics|November 1, 1980
Concentrations and kinetics of carbamazepine in whole saliva, parotid saliva, serum ultrafiltrate, and serumJ W Paxton, R A DonaldThe Analyst|August 1, 1997
Recovery of some common solvents from an adhesive commercial skin adsorption pad by thermal desorption-gas chromatographyF J Rowell, A Fletcher, C PackhamAnnals of Clinical Biochemistry|July 1, 1983
Direct determination of primidone in serum or plasma by a magnetisable solid-phase fluoroimmunoassayA M Sidki, F J Rowell, J LandonJournal of Chromatography|June 29, 1990
Quantitation of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in plasma by high-performance liquid chromatographyD Young, P C Evans, J W PaxtonCancer Chemotherapy and Pharmacology|January 1, 1992
Comparison of the blood-brain barrier and liver penetration of acridine antitumor drugsE M Cornford, D Young, J W PaxtonBritish Journal of Clinical Pharmacology|April 1, 1977
Phenytoin concentrations in mixed, parotid and submandibular saliva and serum measured by radioimmunoassayJ W Paxton, B Whiting, K W StephenPageof 11